Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Medical Decision Making : an International Journal of the Society for Medical Decision Making|July 1, 1996
Willingness to pay for reductions in angina pectoris attacksB Kartman, F Andersson, M JohannessonHealth Economics|November 1, 1996
Valuation of health changes with the contingent valuation method: a test of scope and question order effectsB Kartman, N O Stålhammar, M JohannessonClinical and Experimental Hypertension (New York, N.Y. : 1993)|November 17, 1998
Cost-effectiveness of felodipine-metoprolol (Logimax) and enalapril in the treatment of hypertensionF Andersson, B Kartman, O K AnderssonHealth Economics|February 18, 1998
Contingent valuation with an open-ended follow-up question: a test of scope effectsB Kartman, N O Stålhammar, M JohannessonJournal of Medical Economics|June 30, 2016
The cost-effectiveness of exenatide twice daily (BID) vs insulin lispro three times daily (TID) as add-on therapy to titrated insulin glargine in patients with type 2 diabetesJ Gordon, P McEwan, U Sabale, et al.Journal of Human Hypertension|April 1, 2005
The cost-effectiveness of candesartan-based antihypertensive treatment for the prevention of nonfatal stroke: results from the Study on COgnition and Prognosis in the ElderlyJ Lundkvist, M Ekman, B Kartman, et al.Gene|June 12, 1996
Inhibition of Serratia marcescens nuclease secretion by a truncated nuclease peptideY C Chen, Y Suh, E Riise, et al.Journal of Medical Economics|June 17, 2016
Cost-effectiveness analysis of exenatide once-weekly versus dulaglutide, liraglutide, and lixisenatide for the treatment of type 2 diabetes mellitus: an analysis from the UK NHS perspectiveL H Chuang, B G Verheggen, M Charokopou, et al.Pageof 1